Provided by Tiger Fintech (Singapore) Pte. Ltd.

GENOR-B

3.280
-0.010-0.30%
Volume:1.04M
Turnover:3.56M
Market Cap:1.73B
PE:-29.99
High:3.530
Open:3.480
Low:3.200
Close:3.290
52wk High:5.600
52wk Low:1.360
Shares:528.00M
HK Float Shares:528.00M
Volume Ratio:4.15
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.109
ROE:2.56%
ROA:1.50%
PB:1.44
PE(LYR):-29.99
PS:7.06

Loading ...

Genor Biopharma (06998) Publishes October 2025 Monthly Return with No Change in Issued Share Capital

Bulletin Express
·
Nov 05

Genor Biopharma (6998) Announces Progress on Proposed Merger and Circular Dispatch Delay

Bulletin Express
·
Oct 27

GENOR-B (06998) Issues 684,100 Shares Due to Vesting of Restricted Share Units Under 2023 RSU Plan

Stock News
·
Sep 03

Genor Biopharma Files Next Day Disclosure with HKEX: Announces Increase of 1,190,971 New Shares at HKD 1.5 and HKD 1.808

Reuters
·
Sep 03

GENOR-B (06998) Reports Interim Results with Gross Profit of RMB 32.245 Million, Up 128.35% Year-over-Year

Stock News
·
Aug 29

Genor Biopharma Reports 122% Increase in Revenue to RMB32.2 Million for H1 2025

Reuters
·
Aug 29

Stock Track | Genor Biopharma Plummets 7.40% Amid Broader Biotech Sector Decline in Hong Kong

Stock Track
·
Aug 27

HK Movers | Biotech Stocks Decline, Clover Biopharmaceuticals Drops Over 14%

Tiger Newspress
·
Aug 27

Breaking Traditional IPO Barriers! Yiteng Achieves Backdoor Listing Through GENOR-B

Deep News
·
Aug 14

GENOR-B (06998) Issues 225,800 Shares Under 2021 Restricted Share Unit Plan

Stock News
·
Aug 07

HK Movers | Biotech Stocks Extend Rally. Junshi Bio up over 24%; Genor up 23%; Ascletis up 15%; Ascentage up 13%; Dualitybio up 12%

Tiger Newspress
·
Aug 05

Genor Biopharma Proposes Company Name Change

Reuters
·
Jul 25

Genor Biopharma Announces Progress in Clinical Evaluation of Novel T-Cell Engager GB261 for Autoimmune Diseases

Reuters
·
Jun 30

Genor Biopharma Delays Financial Reporting Circular Again

Reuters
·
Jun 26

Genor Biopharma Holdings Ltd. Conducted Annual General Meeting

Reuters
·
Jun 26

Genor Biopharma Holdings Ltd. Provides Monthly Update on Proposed Merger and Related Transactions

Reuters
·
Jun 13

Genor Biopharma Secures NMPA Approval for Lerociclib to Treat Advanced Breast Cancer

Reuters
·
May 29